» Articles » PMID: 38849920

The Brain-bone Axis: Unraveling the Complex Interplay Between the Central Nervous System and Skeletal Metabolism

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2024 Jun 7
PMID 38849920
Authors
Affiliations
Soon will be listed here.
Abstract

The brain-bone axis has emerged as a captivating field of research, unveiling the intricate bidirectional communication between the central nervous system (CNS) and skeletal metabolism. This comprehensive review delves into the current state of knowledge surrounding the brain-bone axis, exploring the complex mechanisms, key players, and potential clinical implications of this fascinating area of study. The review discusses the neural regulation of bone metabolism, highlighting the roles of the sympathetic nervous system, hypothalamic neuropeptides, and neurotransmitters in modulating bone remodeling. In addition, it examines the influence of bone-derived factors, such as osteocalcin and fibroblast growth factor 23, on brain function and behavior. The therapeutic potential of targeting the brain-bone axis in the context of skeletal and neurological disorders is also explored. By unraveling the complex interplay between the CNS and skeletal metabolism, this review aims to provide a comprehensive resource for researchers, clinicians, and students interested in the brain-bone axis and its implications for human health and disease.

Citing Articles

Divalent metal ions enhance bone regeneration through modulation of nervous systems and metabolic pathways.

Luo Y, Liu B, Qiu Y, Li L, Yang F, Zhang C Bioact Mater. 2025; 47:432-447.

PMID: 40034410 PMC: 11872643. DOI: 10.1016/j.bioactmat.2025.01.034.


Association between stroke and fracture and the mediating role of depression: a cross-sectional study from NHANES 2017 to 2020.

Dan Y, Pei X, Xu D, Liu Z, Wang Y, Yin M Front Neurol. 2025; 16:1533565.

PMID: 39974359 PMC: 11835685. DOI: 10.3389/fneur.2025.1533565.


Comment on "Osteoporosis in older patients with idiopathic normal pressure hydrocephalus".

Mo S, Gu Y Osteoporos Int. 2025; .

PMID: 39932583 DOI: 10.1007/s00198-025-07416-1.


The potential link between the development of Alzheimer's disease and osteoporosis.

Nasme F, Behera J, Tyagi P, Debnath N, Falcone J, Tyagi N Biogerontology. 2025; 26(1):43.

PMID: 39832071 DOI: 10.1007/s10522-024-10181-z.


Unraveling the Mechanism of Impaired Osteogenic Differentiation in Osteoporosis: Insights from Gene Polymorphism.

Krasnova O, Sopova J, Kovaleva A, Semenova P, Zhuk A, Smirnova D Cells. 2025; 13(24.

PMID: 39768200 PMC: 11674950. DOI: 10.3390/cells13242110.


References
1.
Rousseaud A, Moriceau S, Ramos-Brossier M, Oury F . Bone-brain crosstalk and potential associated diseases. Horm Mol Biol Clin Investig. 2016; 28(2):69-83. DOI: 10.1515/hmbci-2016-0030. View

2.
Maradit-Kremers H, Crowson C, Nicola P, Ballman K, Roger V, Jacobsen S . Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005; 52(2):402-11. DOI: 10.1002/art.20853. View

3.
Yorgan T, Peters S, Jeschke A, Benisch P, Jakob F, Amling M . The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5. J Bone Miner Res. 2015; 30(7):1175-83. DOI: 10.1002/jbmr.2461. View

4.
Naude P, Nyakas C, Eiden L, Ait-Ali D, van der Heide R, Engelborghs S . Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J. 2012; 26(7):2811-23. PMC: 3382095. DOI: 10.1096/fj.11-202457. View

5.
Ferreira A, Da Mesquita S, Sousa J, Correia-Neves M, Sousa N, Palha J . From the periphery to the brain: Lipocalin-2, a friend or foe?. Prog Neurobiol. 2015; 131:120-36. DOI: 10.1016/j.pneurobio.2015.06.005. View